Novus Therapeutics
Why Robinhood?
You can watch NVUS and buy or sell other stocks, ETFs, and their options commission-free!About NVUS
Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for people requiring an organ or cellular transplant, and for people living with autoimmune and neurodegenerative disease. The firm’s compound in development is AT-1501, a humanized IgG1 anti-CD40L antibody with high affinity for CD40 ligand (CD40L, also called CD154), a well-validated biological target with broad therapeutic potential.
NVUS Key Statistics
Stock Snapshot
The current Novus Therapeutics(NVUS) stock price is $9.30, with a market capitalization of 556.9M. The stock trades at a price-to-earnings (P/E) ratio of -2.41.
During the trading day, Novus Therapeutics(NVUS) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Novus Therapeutics(NVUS) stock has reached 0, versus its average volume of 1.3M.
Over the past 52 weeks, Novus Therapeutics(NVUS) stock has traded between a high of $4.60 and a low of $1.35.
Over the past 52 weeks, Novus Therapeutics(NVUS) stock has traded between a high of $4.60 and a low of $1.35.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.